Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.

TriVib 5L

This page contains information on TriVib 5L for veterinary use.
The information provided typically includes the following:
  • TriVib 5L Indications
  • Warnings and cautions for TriVib 5L
  • Direction and dosage information for TriVib 5L

TriVib 5L

This treatment applies to the following species:
Manufacturer: Boehringer Ingelheim

Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

For vaccination of healthy cattle as an aid in the prevention of Campylobacter fetus, Leptospira pomona, hardjo, grippotyphosa, canicola and icterohaemorrhagiae infections.

Killed, concentrated cultures of Campylobacter fetus var. venerealis and Leptospira pomona, hardjo, grippotyphosa, canicola and icterohaemorrhagiae organisms suspended in a special oil adjuvant.

DOSE: Cattle, 5 mL. Inject subcutaneously under aseptic conditions in the neck or behind the shoulder. In non-infected herds and susceptible animals a second dose should be administered 2 to 4 weeks later. The last injection should precede the breeding season by 4 to 8 weeks. Revaccinate annually.

TriVib 5L Caution

Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. Do not vaccinate within 60 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.

Thimerosal added as preservative.

For Veterinary Use Only

© 2002 Fort Dodge Animal Health

Fort Dodge Animal Health, Fort Dodge, Iowa 50501 USA

U.S. Vet. License No. 112

50 mL

10 Doses


250 mL

50 Doses


NAC No.: 10282340

Telephone:   800-325-9167
Fax:   816-236-2717
Every effort has been made to ensure the accuracy of the TriVib 5L information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2018 Animalytix LLC. Updated: 2018-11-30